Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1995
08/17/1995WO1995021607A1 Controlled release hydrogel formulation
08/17/1995DE4421079C1 New chimaeric peptide nucleic acid construct
08/17/1995DE4404202A1 Foam control in emulsions
08/17/1995DE4404200A1 Foam control in emulsions
08/17/1995CA2182978A1 Peptides and methods against diabetes
08/17/1995CA2182960A1 Texaphyrin metal complexes having improved functionalization
08/17/1995CA2182682A1 Immunointeractive molecules-i
08/17/1995CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995CA2182587A1 Controlled release hydrogel formulation
08/17/1995CA2182118A1 Nucleic acid-containing composition, its preparation and use
08/16/1995EP0667355A1 Hirudin derivatives and process for their preparation
08/16/1995EP0667166A1 Emulsion based on 1-alpha,24-dihydroxy-vitamine d3
08/16/1995EP0667163A1 Powder for nasal administration of peptidic or proteinaceous drug
08/16/1995EP0667161A1 Delayed release dosage form comprising clindamycin palmitate
08/16/1995EP0667159A2 Concentrated injectable solution of alcaline metal salts of reduced folates
08/16/1995EP0667154A1 Use of flavolignans as adjuvants in the therapy of tumors
08/16/1995EP0666923A1 Targeted delivery of poly- or oligonucleotides to cells
08/16/1995EP0666911A1 Multidrug resistance gene
08/16/1995EP0666901A1 Method and compositions for removing an alginate from a cutaneous substrate
08/16/1995EP0666752A1 Therapeutic microemulsions
08/16/1995EP0666736A1 Stabilization of fluorocarbon emulsions.
08/16/1995EP0532525B1 New protein-polycation conjugates
08/16/1995EP0372071B1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
08/16/1995CN1106698A Prolonged delivery of peptides
08/16/1995CN1106662A Composition for rectal administration
08/16/1995CN1106661A Preparation for epidermis and process for its preparation
08/16/1995CN1106660A Preparation for epidermis and process for its preparation
08/16/1995CN1106659A Preparation for epidermis and process for its preparation
08/16/1995CN1106656A Sustained release drug formulation containing a tramadol salt
08/15/1995US5442053 Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions
08/15/1995US5442043 Peptide conjugate
08/15/1995US5442033 Liquid copolymers of epsilon-caprolactone and lactide
08/15/1995US5442008 Stabilized polymer film coated compounds and stabilized formulations in compressed from using same
08/15/1995US5441944 Substituted cyclodextrin sulfates and their uses as growth modulating agents
08/15/1995US5441933 Containing diluent, lubricant, disintegrating agent and/or binder
08/15/1995US5441932 Antiallergens, antiinflammatory agents
08/15/1995US5441871 Monoclonal antibody reactive to human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
08/15/1995US5441746 Electromagnetic wave absorbing, surface modified magnetic particles for use in medical applications, and their method of production
08/15/1995US5441739 Reduced and controlled surface binding of biologically active molecules
08/15/1995US5441732 Aqueous and oil emulsions containing atleast one thermosensitive reversible polymer and organic oil for sustained released drug delivery into lacrimal secretions of the eye
08/15/1995CA2007480C Use of the active substance azelastine for the control of psoriasis disorders and inflammatory disorders
08/15/1995CA1336739C Diphosphonate-derivatized macromolecules
08/15/1995CA1336732C Film-forming gels with high concentration of humectants and emollients
08/15/1995CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects
08/15/1995CA1336677C Compositions having use as treatment of psoriasis and neuropsychiatric deficits
08/15/1995CA1336676C Intravaginal delivery of biologically active polypeptides
08/14/1995WO1995024429A1 Highly reactive esters of carboxy polysaccharides and novel carboxy polysaccharides derived therefrom
08/12/1995EP0674510A4 Injectable composition.
08/11/1995CA2142173A1 Hirudin derivatives and a process for their preparation
08/11/1995CA2142142A1 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
08/10/1995WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995WO1995021195A1 Non-viral vector
08/10/1995WO1995021018A1 Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same
08/10/1995WO1995020980A1 Method for increasing bioavailability of oral pharmaceutical compositions
08/10/1995WO1995020970A1 A process for the preparation of bismuth complexes
08/10/1995WO1995020964A1 Oral liquid compositions containing paroxetine resinate
08/10/1995WO1995020956A1 Anti-tumour medical preparation on the basis of carboplatin and the method of its production
08/10/1995WO1995020955A1 Liquid pharmaceutical compositions comprising thyroid hormones
08/10/1995WO1995020951A1 Polymeric adamantane analogues
08/10/1995WO1995020945A1 Lipophilic carrier preparations
08/10/1995WO1995020944A1 Bilayer preparations
08/10/1995WO1995020943A1 Oil-in-water emulsions
08/10/1995WO1995018636A3 Hepatocyte-targeted drug conjugates
08/10/1995DE4435086C1 Conjugate for inducing cellular immunity contains CD8 positive cell epitope
08/10/1995DE4409569C1 New poly:glycerol poly:ricinoleate ester(s)
08/10/1995CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995CA2182616A1 Non-viral vector
08/10/1995CA2182593A1 Oral liquid compositions containing paroxetine resinate
08/10/1995CA2182037A1 Liquid pharmaceutical compositions comprising thyroid hormones
08/10/1995CA2177175A1 Method for increasing bioavailability of oral pharmaceutical compositions
08/09/1995EP0665850A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
08/09/1995EP0665755A1 Preparation of pharmaceutical compositions containing a calcitonin
08/09/1995EP0665746A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF$g(a)PE 40?ab
08/09/1995EP0665745A1 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same
08/09/1995EP0665742A1 Blended lipid vesicles
08/09/1995EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties
08/09/1995EP0656883A4 Cationic lipids.
08/09/1995CN1106608A Controlled release preparation containing a salt of morphine
08/09/1995CN1106259A Antiphlogistic and analgesic gel agent for external use containing propanoic acid non steroid pharmaceutical as effective composition
08/08/1995US5439967 Propylene glycol stearate vesicles
08/08/1995US5439944 Red blood cell substitute emulsions containing alkyl- or alkylglyucerophosphoryl choline surfactants and methods of use
08/08/1995US5439882 Blood substitute
08/08/1995US5439815 Restrictocin-like ribotoxin analogues comprising only one cysteine available for covalent linkage to a partner
08/08/1995US5439687 Dosage forms having zero-order dihydropyridine calcium antagonist release
08/08/1995US5439686 Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
08/08/1995US5439685 Vaginal tampon containing cholic acid or salt as microbiocide, dimethylsiloxane as protective film forming agent, hydroxy-propylmethyl cellulose as thickener, benzalkonium chloride and nonoxynol 9 as spermicidal agents
08/08/1995US5439669 Biological imaging emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
08/08/1995US5439668 Heterocyclic chelating agents
08/08/1995US5439665 Detection and treatment of infectious and inflammatory lesions
08/08/1995CA1336597C Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
08/08/1995CA1336586C Enzyme controlled release system
08/08/1995CA1336585C Method of stabilizing urokinase precursor and dry preparation containing said precursor
08/08/1995CA1336579C Delivery systems for the controlled administration of lhrh analogs
08/03/1995WO1995020591A1 Phenylboronic acid complexes
08/03/1995WO1995020567A1 Codrugs as a method of controlled drug delivery
08/03/1995WO1995020564A1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/03/1995WO1995020542A1 Method of treatment of talc
08/03/1995WO1995020403A1 Aqueous topical compositions
08/03/1995WO1995020401A1 Polyclonal antibody libraries
08/03/1995WO1995020399A1 Pharmaceutical compositions comprising hirudin
1 ... 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 ... 1712